(firstQuint)Long-term Safety Study of the GORE HELEX Septal Occluder.

 The GORE(R) HELEX(R) Septal Occluder is an approved medical device indicated for the transcatheter closure of atrial septal defects (ASDs).

 The purpose of this study is to evaluate the long-term safety and efficacy of the GORE(R) HELEX(R) Septal Occluder in the treatment of ostium secundum atrial septal defects (ASDs).

 This is an FDA Condition of Approval Study.

 All subjects enrolled in this study will be followed for long-term safety and efficacy of the occluder device through 5 years.

.

 Long-term Safety Study of the GORE HELEX Septal Occluder@highlight

The purpose of this study is to evaluate the long-term safety and efficacy of the GORE(R) HELEX(R) Septal Occluder in the treatment of ostium secundum atrial septal defects (ASDs).

